The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
CLE CCC Neutral Deep
Titanium Dioxide, Octinoxate, Octisalate, Avobenzone · OCTINOXATE 2.1 mg/30mL; OCTISALATE .6 mg/30mL; TITANIUM DIOXIDE .279 mg/30mL; AVOBENZONE .156 mg/30mL · Cream · Topical · Kw Absc, Inc.
NDC 69231-0036-02 · 1 CONTAINER in 1 PACKAGE / 30 mL in 1 CONTAINER · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M020
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Titanium Dioxide, Octinoxate, Octisalate, Avobenzone (Cream)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Kw Absc, Inc. | OCTINOXATE 2.1 mg/30mL; OCTISALATE .6 mg/30mL; TITANIUM DIOXIDE .279 mg/30mL; AVOBENZONE .156 mg/30mL | Aug 26, 2026 | Sep 2, 2026 |
| Kw Absc, Inc. | OCTINOXATE 2.1 mg/30mL; OCTISALATE .6 mg/30mL; TITANIUM DIOXIDE .51 mg/30mL; AVOBENZONE .156 mg/30mL | Aug 26, 2026 | Sep 2, 2026 |
| Kw Absc, Inc. | OCTINOXATE .156 mg/30mL; OCTISALATE 2.1 mg/30mL; TITANIUM DIOXIDE .6 mg/30mL; AVOBENZONE .279 mg/30mL | Jul 22, 2026 | Aug 19, 2026 |
| Kw Absc, Inc. | OCTINOXATE .156 mg/30mL; OCTISALATE 2.1 mg/30mL; TITANIUM DIOXIDE .6 mg/30mL; AVOBENZONE .51 mg/30mL | Jul 22, 2026 | Aug 19, 2026 |
| Kw Absc, Inc. | AVOBENZONE .156 mg/30mL; OCTINOXATE 2.1 mg/30mL; OCTISALATE .6 mg/30mL; TITANIUM DIOXIDE .279 mg/30mL | Jul 15, 2026 | Jul 15, 2026 |
| Kw Absc, Inc. | AVOBENZONE .156 mg/30mL; OCTINOXATE 2.1 mg/30mL; OCTISALATE .6 mg/30mL; TITANIUM DIOXIDE .51 mg/30mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "CLE CCC Neutral Deep — NDC 69231-0036-02," retrieved September 3, 2026, https://drugdashboards.com/drug/69231003602.
Free to cite with attribution — see how the data is put together.